mva pvdbp
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01816113)
Timeline
Indications
Mechanism of action
- Plasmodium vivaxImmunity, active
Plasmodium vivax immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva pvdbp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04009096 | Phase 2 | Jul 31, 2019 | University of Oxford |
| NCT01816113 | Phase 1 | Apr 1, 2013 | University of Oxford |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 2 | 2 | 2 | 2013 |
1 organizations
Page 1 / 1